Syed Muhammad Adnan Ali (S M Adnan Ali)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Cancer Stem Cells

Ejection Fraction

Top Venues

Clinical Medicine Insights. Oncology

Journal of cancer epidemiology

International journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Tabish Chawla, Syed Muhammad Adnan Ali
Significant Association of PD-L1 With CD44 Expression and Patient Survival: Avenues for Immunotherapy and Cancer Stem Cells Downregulation in Pancreatic Cancers. Journal of cancer epidemiology 2024 (2024)
Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Tabish Chawla, Syed Muhammad Adnan Ali
Significant Association of PD-L1 With CD44 Expression and Patient Survival: Avenues for Immunotherapy and Cancer Stem Cells Downregulation in Pancreatic Cancers. Journal of cancer epidemiology 2024 (2024)
Yumna Adnan, Syed Muhammad Adnan Ali, Hasnain Ahmed Farooqui, Hammad Afzal Kayani, Romana Idrees, Muhammad Sohail Awan
High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan. International journal of surgical oncology 2022 (2022)
Yumna Adnan, Syed Muhammad Adnan Ali, Muhammad Sohail Awan, Nida Zahid, Muhammad Ozair Awan, Hammad Afzal Kayani, Hasnain Ahmed Farooqui
Body Mass Index and Diabetes Mellitus May Predict Poorer Overall Survival of Oral Squamous Cell Carcinoma Patients: A Retrospective Cohort From a Tertiary-Care Centre of a Resource-Limited Country. Clinical Medicine Insights. Oncology 16 (2022)
Syed Muhammad Adnan Ali, Yumna Adnan, Saleema Mehboob Ali, Zubair Ahmad, Tabish Chawla, Hasnain Ahmed Farooqui
Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma. Journal of cancer research and clinical oncology (2022)
Syed Muhammad Adnan Ali, Muhammad Shahzad Shamim, Syed Ather Enam, Zubair Ahmad, Yumna Adnan, Hasnain Ahmed Farooqui
Immunohistochemical Detection and Prognostic Significance of p53, Epidermal Growth Factor Receptor, Murine Double Minute 2, and Isocitrate Dehydrogenase 1 in Glioblastoma Multiforme Patients of Pakistan. Clinical Medicine Insights. Oncology 16 (2022)
Yumna Adnan, Syed Muhammad Adnan Ali, Muhammad Sohail Awan, Romana Idress, Muhammad Ozair Awan, Hasnain Ahmed Farooqui, Hammad Afzal Kayani
Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population. PloS one 17 (5) (2022)